Nordic guidelines 2014 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms

Eva Tiensuu Janson, Halfdan Sorbye, Staffan Welin, Birgitte Federspiel, Henning Gronbaek, Per Hellman, Morten Ladekarl, Seppo W. Langer, Jann Mortensen, Camilla Schalin-Jantti, Anders Sundin, Anna Sundlöv, Espen Thiis-Evensen, Ulrich Knigge

Forskningsoutput: TidskriftsbidragÖversiktsartikelPeer review

Sammanfattning

Background. The diagnostic work-up and treatment of patients with neuroendocrine neoplasms (NENs) has undergone major recent advances and new methods are currently introduced into the clinic. An update of the WHO classification has resulted in a new nomenclature dividing NENs into neuroendocrine tumours (NETs) including G1 (Ki67 index <= 2%) and G2 (Ki67 index 3-20%) tumours and neuroendocrine carcinomas (NECs) with Ki67 index > 20%, G3. Aim. These Nordic guidelines summarise the Nordic Neuroendocrine Tumour Group's current view on how to diagnose and treat NEN-patients and are meant to be useful in the daily practice for clinicians handling these patients.
Originalspråkengelska
Sidor (från-till)1284-1297
TidskriftActa Oncologica
Volym53
Nummer10
DOI
StatusPublished - 2014

Ämnesklassifikation (UKÄ)

  • Cancer och onkologi

Fingeravtryck

Utforska forskningsämnen för ”Nordic guidelines 2014 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms”. Tillsammans bildar de ett unikt fingeravtryck.

Citera det här